Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Sentinel Lymph Node
Interventions: DRUG: Tilmanocept|DRUG: Nanocolloid
Sponsor: University Hospital, Ghent
Collaborators: Norgine